Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

Maternal Cardiac Function in Pregnancies With Metabolic Disorders

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e08.

Treatment Options and Continuity of Care in MAFLD

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e06.

Obesity in Asia-Pacific

Published:

05 June 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e21.

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.